Redx Pharma PLC (FRA:0RX)
€ 0.167 0 (0%) Market Cap: 64.96 Mil Enterprise Value: 64.48 Mil PE Ratio: 0 PB Ratio: 15.00 GF Score: 33/100

Half Year 2023 Redx Pharma PLC Earnings Call Transcript

May 17, 2023 / 11:00AM GMT
Release Date Price: €0.34 (-9.09%)
Rachel Curtis Gravesen;Lisa Anson<
Curtis Consult - IR

Hello and welcome. Thanks for joining us for today's call to discuss Redx's interim results for the period ended March 31, 2023. I'm Rachel Curtis Gravesen. And in a moment, Redx's Chief Executive Officer, Lisa Anson; Chief Financial Officer, Pete Collum; and Chief Scientific Officer, Richard Armer; and Dr. Jane Robertson, the company's Chief Medical Officer, will present the progress made during this time by the company.

(Event Instructions)

But now, could we please move to the next slide? Because importantly, before we begin the actual presentation, I'd like to draw your attention to the disclaimer slide we have here on slide 2 and remind you that any statements made during this call that are not historical statements will be forward-looking statements. And as such, that means they'll be subject to risks and uncertainties, which, if they should materialize, could materially affect Redx's share price.

With that, I'd like to hand the call over to Redx's CEO, Lisa Anson, so she can begin the presentation.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot